| Title |
Date |
Price |
|
As end users become increasingly interested in integrated clinical chemistry and immunoassay systems, manufacturers continuing to produce only stand-alone systems may stand to lose market share. By evaluating... |
Feb, 1999 |
€3 325 |
|
Infection prevention and control is an integrated, responsive process that is applied to all programs, services and settings and requires collaboration throughout the organization to develop, implement,... |
Dec, 2005 |
€70 |
|
This Frost & Sullivan report forecasts opportunities for growth in the U.S. DNA/RNA probe diagnostic systems marketplace, identifies key industry issues and trends, and provides analysis of products and... |
Feb, 1999 |
€2 578 |
|
Lasers for aesthetic use have shown a great deal of innovation over the past three years. This report evaluates the current state of the U.S. aesthetic laser market and forecasts future revenues, product... |
Mar, 1999 |
€2 578 |
|
This report segments ultrasound diagnostic equipment markets according to unit prices and also provides in-depth analyses for each geographic region. By evaluating the short- and long-term impact of the... |
Mar, 1999 |
€2 204 |
|
Abundant opportunities for growth provide participants and observers of the world nuclear medical imaging equipment markets with more reason for an optimistic outlook than ever before. This report covers... |
Apr, 1999 |
€2 951 |
|
As the healthcare industry evolves into fewer but larger institutions, bigger and more expensive laboratory systems will be required to meet the resultant computing needs. This report provides insight... |
Mar, 1999 |
€2 951 |
|
Sleep disorders has been a growing concern in the U.S., with an estimated 40 million Americans suffering from such afflictions. This report evaluates current states of the sleep disorder diagnostic and... |
Aug, 1999 |
€2 951 |
|
The Chinese markets for diagnostic ultrasound equipment have seen double-digit growth over the last few years. This report analyzes the Chinese markets for both black-and-white and color ultrasound equipment.... |
Jul, 1999 |
€2 204 |
|
The European markets for medical diagnostic ultrasound equipment are projected to see extensive growth throughout the forecast period. Along with forecasting future revenues and pricing trends for the... |
Sep, 1999 |
€3 101 |
|
This report covers the markets for major HIV/AIDS drug therapies, including protease inhibitors (PIs), nucleoside reverse transcriptase inhibitors (NRTIs), and non-nucleoside reverse transcriptase inhibitors... |
Sep, 1999 |
€2 951 |
|
Because Indian doctors have a high degree of awareness of the latest treatment technologies, demand for the two medical imaging modalities covered in this report from Frost & Sullivan continues to rise.... |
Nov, 1997 |
€1 457 |
|
Based on a 34-question survey, Bioassays is the fourth of six titles in the series, The Tools and Techniques of Drug Discovery, and specifically provides valuable insight into the two major types of bioassays... |
May, 2002 |
€856 |
|
This industry comprises establishments known as medical and diagnostic laboratories primarily engaged in providing analytic or diagnostic services, including body fluid analysis and diagnostic imaging,... |
Jan, 2007 |
€765 |
|
This report from Frost & Sullivan divides the in-vitro cancer diagnostics market into an in-depth analysis in each of the four segments - immunoassay, immuno-histochemistry, clinical chemistry and nucleic... |
Jun, 2000 |
€3 101 |
|
MRI Pushes its Limits in Field Strength, Openness and Price ImplementationChallengeIdentificationHigh field strength is crucial for obtaining the best quality MRI image. Moreand more, applications in the... |
Jul, 2000 |
€2 951 |
|
Healthcare Reforms Encourage Strategic Alliances Ultrasound imaging is a safe, non-invasive, non-ionizing procedure that makes it a routine treatment choice among physicians. However, continued cost-containment... |
Apr, 2001 |
€4 670 |
|
Three-Dimensional Imaging Moves From The Drawing Board To The ClinicThe market for 3-D imaging technologies used in medical applications hasclearly passed from the research stage to product development... |
Apr, 2001 |
€3 699 |
|
New Product Classes Offer Significant Growth Opportunities The emergence of leukotriene modifiers and combination therapies showpromise in a highly competitive market. Leukotriene modifiers aremaintenance... |
Apr, 2001 |
€3 542 |
|
Already a leading cause of death, stroke cases are expected to double duringthe next half century. Consequently, the markets for stroke therapies offerimportant opportunities for companies that can overcome... |
May, 2001 |
€3 699 |